Endothelin-1 decreases endothelial PPARγ signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 306, Issue 4, 2014, Pages

  Wolf, David ^a   Tseng, Nancy ^a   Seedorf, Gregory ^a   Roe, Gates ^a   Abman, Steven H ^a   Gien, Jason ^a  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

Author keywords

Angiogenesis; Endothelin 1 (ET 1); Peroxisome proliferator activated receptor gamma (PPAR ); Persistent pulmonary hypertension of the newborn (PPHN); Pulmonary artery endothelial cell

Indexed keywords

ANGIOGENESIS; ENDOTHELIN-1 (ET-1); PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARΓ); PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN (PPHN); PULMONARY ARTERY ENDOTHELIAL CELL;

ANIMALS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIN-1; HUMANS; INFANT, NEWBORN; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PERSISTENT FETAL CIRCULATION SYNDROME; PPAR GAMMA; PULMONARY ARTERY; RECEPTORS, ENDOTHELIN; SHEEP; SIGNAL TRANSDUCTION; SULFONAMIDES;

EID: 84894098025     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00277.2013     Document Type: Article

References (63)

1. Abbott BD, Wood CR, Watkins A, Das KP, Lau CS. Peroxisome proliferator-activated receptors alpha, beta, and gamma mRNA and protein expression in human fetal tissues. PPAR Res 2010: 1-19, 2010.
2. Abman SH, Shanley PF, Accurso FJ. Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs. J Clin Invest 83: 1849-1858, 1989.
3. Ameshima S, Golpon H, Cool C, Chan D, Vandiver RW, Gardai S, Wick M, Nemenoff R, Geraci M, Voelkel N. Peroxisome proliferatoractivated receptor gamma (PPARγ) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circ Res 92: 1162-1169, 2003.
4. Atkins KB, Irey B, Xiang N, Brosius FC 3rd. A rapid, PPAR-γ-dependent effect of pioglitazone on the phosphorylation of MYPT. Am J Physiol Cell Physiol 296: C1151-C1161, 2009.
5. Balasubramaniam V, Maxey AM, Fouty BW, Abman SH. Nitric oxide augments fetal pulmonary artery endothelial cell angiogenesis in vitro. Am J Physiol Lung Cell Mol Physiol 290: L1111-L1116, 2006.
6. Baquero H, Soliz A, Neira F, Venegas M, Sola A. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 117: 1077-1083, 2006.
7. Belik J, Kelley FW, Baldwin F, Rabinovitch M. Pulmonary hypertension and vascular remodeling in fetal sheep. Am J Physiol Heart Circ Physiol 266: H2303-H2309, 1994.
8. Crossno JT, Garat CV, Reusch JEB, Morris KG, Dempsey EC, McMurtry IF, Stenmark KR, Klemm DJ. Rosi attenuates hypoxiainduced pulmonary arterial remodeling. Am J Physiol Lung Cell Mol Physiol 292: L885-L897, 2007.
9. Calnek DS, Mazzella L, Roser S, Roman J, Hart MC. Peroxisome proliferator-activated receptor γ ligands increase release of nitric oxide from endothelial cells. Arterioscler Thromb Vasc Biol 23: 52-57, 2003.
10. Cardillo C, Kilcoyne CM, Cannon RO 3rd, Panza JA. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo. Hypertension 35: 1237-1241, 2000.
11. Clark R, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, Kinsella JP. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 342: 469-474, 2000.
12. Chen SJ, Chen YF, Chen QC, Durand J, Dicarlo VS, Oparil S. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J Appl Physiol 79: 2122-2131, 1995.
13. TB receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 165: 398-405, 2002.
14. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20: 649-688, 1999.
15. de Vroomen M, Lopes Cardozo RH, Steendijk P, Frölich M, Baan J, van Bel F. Endothelin-1 plasma concentration increases in the early phase of pulmonary hypertension development during respiratory distress syndrome: a study in newborn lambs. Early Hum Dev 63: 9-21, 2001.
16. Dong F, Zhang X, Wold LE, Ren Q, Zhang Z, Ren J. Endothelin-1 enhances oxidative stress. cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin-1. Br J Pharmacol 145: 323-333, 2005.
17. D'Orleans-Juste P, Claing A, Telemaque S, Maurice MC, Yano M, Gratton JP. Block of endothelin-1-induced release of thromboxane A2 from the guinea pig lung and nitric oxide from the rabbit kidney by a selective ETB receptor antagonist, BQ-788. Br J Pharmacol 113: 1257-1262, 1994.
18. Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahlit W. Control of the peroxisomal p-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68: 879-887, 1992.
19. El Sayed M, Sherif L, Said RN, El-Wakkad AS, El-Refay A, Aly H. Endothelin-1 and L-arginine in preterm infants with respiratory distress. Am J Perinatol 2: 129-136, 2011.
20. Gien J, Tseng N, Seedorf G, Roe G, Abman SH. Endothelin-1 impairs angiogenesis in vitro through Rho-kinase activation after chronic intrauterine pulmonary hypertension in fetal sheep. Pediatr Res 73: 252-262, 2013.
21. Gien J, Seedorf G, Balasubramaniam V, Markham N, Abman SH. Chronic intrauterine pulmonary hypertension impairs angiogenesis and growth of ovine fetal pulmonary artery endothelial cells in vitro. Am J Respir Crit Care Med 176: 1146-1153, 2007.
22. Goldman AP, Tasker RC, Haworth SG, Sigston PE, Macrae DJ. Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 98: 706-713, 1996.
23. Goya K, Sumitani S, Otsuki M, Xu X, Yamamoto H, Kurebayashi S, Saito H, Kouhara H, Kasayama S. The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells. J Diabetes Complications 20: 336-342, 2006.
24. Grover TR, Parker TA, Balasubramaniam V, Markham NE, Abman SH. Pulmonary hypertension impairs alveolarization and reduces lung growth in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 288: L648-L654, 2005.
25. Hansmann G, de Jesus Perez VA, Alastalo TP, Alvira CM, Guignabert C, Bekker JM, Schellong S, Urashima T, Wang L, Morrell NW, Rabinovitch M. An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest 118: 1846-1857, 2008.
26. Hopkins N, McLoughlin P. The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis? J Anat 201: 335-348, 2002.
27. Howell K, Preston RJ, McLoughlin P. Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulation. J Physiol 547: 133-145, 2003.
28. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645-649, 1990.
29. Ivy DD, le Cras TD, Parker TA, Zenge JP, Jakkula M, Markham NE, Kinsella JP, Abman SH. Developmental changes in endothelin expression and activity in the ovine fetal lung. Am J Physiol Lung Cell Mol Physiol 278: L785-L793, 2000.
30. Ivy DD, Dubus JW, Fox MF, Fox JJ, Kinsella JP, Abman SH. Chronic intrauterine pulmonary hypertension alters endothelin receptor activity in the ovine fetal lung. Pediatr Res 39: 435-442, 1996.
31. Ivy DD, Parker TA, Ziegler JW, Galan HL, Kinsella JP, Tuder RM, Abman SH. Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus. J Clin Invest 99: 1179-1186, 1997.
32. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Abman SH. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 279: L600-L607, 2000.
33. Kang BY, Kleinhenz JM, Murphy TC, Hart CM. The PPARγ ligand rosiglitazone attenuates hypoxia-induced endothelin signaling in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 301: L881-L891, 2011.
34. Keller RL, Tacy TA, Hendricks-Munoz K, Xu J, Moon-Grady AJ, Neuhaus J, Moore P, Nobuhara KK, Hawgood S, Fineman JR. Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity. Am J Respir Crit Care Med 182: 555-561, 2010.
35. Kim EK, Lee J, Oh Y, Lee Y, Lee S. Rosiglitazone attenuates hypoxiainduced pulmonary arterial hypertension in rats. Respirology 15: 659-668, 2010.
36. Kinsella J, Truog WE, Walsh WF, Golberg RN, Bacalari E, Mayock D, Redding G, deLemos R, Sardesai S, McCurnin D, Moreland S, Cutter G, Abman S. Randomized, multicenter trial of inhaled nitric oxide and high frequency oscillatory ventilation in severe persistent pulmonary hypertension of the newborn. J Pediatr 131: 55-62, 1997.
37. Kleinhenz JM, Kleinhenz DJ, You S, Ritzenthaler JD, Hansen JM, Archer DR, Sutliff RL, Hart CM. Disruption of endothelial peroxisome proliferator-activated receptor-reduces vascular nitric oxide production. Am J Physiol Heart Circ Physiol 297: H1647-H1654, 2009.
38. Kobayashi H, Puri P. Plasma endothelin levels in congenital diaphragmatic hernia. J Pediatr Surg 29: 1258-1261, 1994.
39. Konduri GG, Ou J, Shi Y, Kirkwood AP Jr. Decreased association of HSP90 impairs endothelial nitric oxide synthase in fetal lambs with persistent pulmonary hypertension. Am J Physiol Heart Circ Physiol 285: H204-H211, 2003.
40. Laudet V, Hanni C, Coll J, Catzefilis F, Stehelin D. Evolution of the nuclear receptor gene superfamily. EMBO J 11: 1003-1013, 1992.
41. Levin DL, Heymann MA, Kitterman JA, Gregory GA, Phibbs RH, Rudolph AM. Persistent pulmonary hypertension of the newborn infant. J Pediatr 89: 626-630, 1976.
42. Lin Q, Fang LP, Zhou WW, Liu XM. Rosi inhibits migration, proliferation, and phenotypic differentiation in cultured human lung fibroblasts. Exp Lung Res 36: 120-128, 2010.
43. Miyauchi T, Yorikane R, Sakai S, Sakurai T, Okada M, Nishikibe M, Yano M, Yamaguchi I, Sugishita Y, Goto K. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 73: 887-897, 1993.
44. Morin F III. Ligating the ductus arteriosis before birth causes persistent pulmonary hypertension in the newborn lamb. Pediatr Res 25: 245-250, 1989.
45. Murphy JD, Rabinovitch M, Goldstein JD, Reid LM. The structural basis of persistent pulmonary hypertension of the newborn infant. J Pediatr 98: 962-967, 1981.
46. Neonatal Inhaled Nitric Oxide Study Group (NINOS). Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 336: 597-601, 1997.
47. Neonatal Inhaled Nitric Oxide Study Group (NINOS). Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. Pediatrics 99: 838-845, 1997.
48. Nicola T, Ambalavanana N, Zhang W, James ML, Rehan V, Halloran B, Olave N, Bulger A, Oparil S, Chen Y. Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. Am J Physiol Lung Cell Mol Physiol 301: L125-L134, 2011.
49. Nisbet RE, Bland JM, Kleinhenz DJ, Mitchell PO, Walp ER, Sutliff RL, Hart CM. Rosi attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model. Am J Respir Cell Mol Biol 42: 482-490, 2010.
50. Niu JO, Munshi UK, Siddiq MM, Parton LA. Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia. J Pediatr 132: 965-970, 1998.
51. Polikandroitis JA, Mazzella LJ, Rupnow HL, Hart MC. Peroxisome proliferator-activated receptor γ ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor γ-dependent mechanisms. Arterioscler Thromb Vasc Biol 25: 1810-1816, 2005.
52. Roberts JD, Fineman JR, Morin FC III, Shaul PW, Rimar S, Schreiber MD, Polin R, Zwass M, Zayek M, Gross I, Heymann MA, Zapol WM. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 336: 605-610, 1997.
53. Rosenberg AA, Kennaugh J, Koppenhafer SL, Loomis M, Chatfield BA, Abman SH. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr 123: 109-114, 1993.
54. Ross R, Raines EW, Bowen-Pope DF. Sera and conditioned media contain different isoforms of platelet-derived growth factor (PDGF) which bind to different classes of PDGF receptor. J Biol Chem 264: 2502, 1989.
55. Salani D, Taraboletti G, Rosano L, Di Castro V, Borsotti P, Giavazzi R, Bagnato A. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol 157: 1703-1711, 2000.
56. Simon DM, Tsai LW, Ingenito EP, Starcher B, Mariani TJ. PPARγ deficiency results in reduced lung elastic recoil and abnormalities in airspace distribution. Respir Res 11: 69, 2010.
57. Sun L, Tran N, Liang C, Tang G, Rice A, Schreck R, Waltz K, Shawver LK, McMahon G, Tang C. Design, synthesis, and evaluations of substituted 3-[(3-or 4-carboxyethylpyrrol-2-yl)methylidenyl] indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases. J Med Chem 42: 5120-5130, 1999.
58. Takeda K, Okamoto M, De Langhe S, Dill E, Armstrong M, Reisdorf N, Irwin D, Koster M, Wilder J, Stenmark KR, West J, Klemm D, Gelfand EW, Nozik-Grayck E, Majka SM. Peroxisome proliferatoractivated receptor γ agonist treatment increases septation and angiogenesis and decreases airway hyperresponsiveness in a model of experimental neonatal chronic lung disease. Anat Rec 292: 1045-1061, 2009.
59. Wakino S, Hayashi K, Kanda T, Tatematsu S, Homma K, Yoshioka K, Takamatsu I, Saruta T. Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2. Circ Res 95: e45-e55, 2004.
60. Walsh M, Stork EK. Persistent pulmonary hypertension of the newborn rational therapy based on pathophysiology. Clin Perinatol 28: 609-627, 2001.
61. Wild LM, Nickerson PA, Morin FC III. Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb. Pediatr Res 25: 251-257, 1989.
62. Wong J, Fineman JR, Heymann MA. The role of endothelin and endothelin receptor subtypes in regulation of fetal pulmonary vascular tone. Pediatr Res 35: 664-670, 1994.
63. Zöllner S, Aberle S, Harvey SE, Polokoff MA, Rubanyi GM. Changes of endothelial nitric oxide synthase level and activity during endothelial cell proliferation. Endothelium 7: 169-184, 2000.